Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Reprints and Permissions
	Copyright Information
	Books from ASM Press
	MicrobeWorld

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Espinel-Ingroff, A.
	Articles by Weitzman, I.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Espinel-Ingroff, A.
	Articles by Weitzman, I.

Previous Article | Next Article

Journal of Clinical Microbiology, Jan 1997, 139-143, Vol 35, No. 1
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

A Espinel-Ingroff, M Bartlett, R Bowden, NX Chin, C Cooper Jr, A Fothergill, MR McGinnis, P Menezes, SA Messer, PW Nelson, FC Odds, L Pasarell, J Peter, MA Pfaller, JH Rex, MG Rinaldi, GS Shankland, TJ Walsh and I Weitzman
Medical College of Virginia/Virginia Commonwealth University, Richmond 23298-0049, USA.

A multicenter study was conducted to expand the generation and analysis of data that supports the proposal of a reference method for the antifungal susceptibility testing of filamentous fungi. Broth microdilution MICs of amphotericin B and itraconazole were determined in 11 centers against 30 coded duplicate pairs of Aspergillus spp., Fusarium spp., Pseudallescheria boydii, and Rhizopus arrhizus. The effect of inoculum density (approximately 10(3) and 10(4) CFU/ml), incubation time (24, 48, and 72 h), and procedure of MIC determination (conventional and colorimetric [Alamar Blue] evaluation of growth inhibition) on intra- and interlaboratory agreement was analyzed. Based on intra- (97 to 100%) and interlaboratory (94 to 95%) agreement for both drugs, the overall optimal testing conditions identified were determination of colorimetric MICs after 48 to 72 h of incubation with an inoculum density of approximately 10(4) CFU/ml. These testing conditions are proposed as guidelines for a reference broth microdilution method.

This article has been cited by other articles:

Espinel-Ingroff, A., Canton, E. (2008). Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol. 46: 1793-1803 [Abstract] [Full Text]
Pereira, D. I. B., Santurio, J. M., Alves, S. H., Argenta, J. S., Potter, L., Spanamberg, A., Ferreiro, L. (2007). Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals. J Antimicrob Chemother 60: 1168-1171 [Abstract] [Full Text]
Espinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M. A., Rinaldi, M. G., Schell, W., Walsh, T. J. (2007). Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds. J. Clin. Microbiol. 45: 2180-2182 [Abstract] [Full Text]
Espinel-Ingroff, A., Arthington-Skaggs, B., Iqbal, N., Ellis, D., Pfaller, M. A., Messer, S., Rinaldi, M., Fothergill, A., Gibbs, D. L., Wang, A. (2007). Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin. J. Clin. Microbiol. 45: 1811-1820 [Abstract] [Full Text]
Lalitha, P., Shapiro, B. L., Srinivasan, M., Prajna, N. V., Acharya, N. R., Fothergill, A. W., Ruiz, J., Chidambaram, J. D., Maxey, K. J., Hong, K. C., McLeod, S. D., Lietman, T. M. (2007). Antimicrobial Susceptibility of Fusarium, Aspergillus, and Other Filamentous Fungi Isolated From Keratitis. Arch Ophthalmol 125: 789-793 [Abstract] [Full Text]
Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2007). Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J Antimicrob Chemother 59: 230-237 [Abstract] [Full Text]
Petraitis, V., Petraitiene, R., Solomon, J., Kelaher, A. M., Murray, H. A., Mya-San, C., Bhandary, A. K., Sein, T., Avila, N. A., Basevicius, A., Bacher, J., Walsh, T. J. (2006). Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.. Antimicrob. Agents Chemother. 50: 1510-1517 [Abstract] [Full Text]
Antachopoulos, C., Meletiadis, J., Roilides, E., Sein, T., Walsh, T. J. (2006). Rapid Susceptibility Testing of Medically Important Zygomycetes by XTT Assay. J. Clin. Microbiol. 44: 553-560 [Abstract] [Full Text]
Santos, D. A., Barros, M. E. S., Hamdan, J. S. (2006). Establishing a Method of Inoculum Preparation for Susceptibility Testing of Trichophyton rubrum and Trichophyton mentagrophytes. J. Clin. Microbiol. 44: 98-101 [Abstract] [Full Text]
Espinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M., Rinaldi, M., Schell, W., Walsh, T. (2005). Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol. 43: 5243-5246 [Abstract] [Full Text]
Lass-Florl, C., Rief, A., Leitner, S., Speth, C., Wurzner, R., Dierich, M. P. (2005). In Vitro Activities of Amphotericin B and Voriconazole against Aleurioconidia from Aspergillus terreus. Antimicrob. Agents Chemother. 49: 2539-2540 [Abstract] [Full Text]
van de Sande, W. W. J., Luijendijk, A., Ahmed, A. O. A., Bakker-Woudenberg, I. A. J. M., van Belkum, A. (2005). Testing of the In Vitro Susceptibilities of Madurella mycetomatis to Six Antifungal Agents by Using the Sensititre System in Comparison with a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5- [(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Assay and a Modified NCCLS Method. Antimicrob. Agents Chemother. 49: 1364-1368 [Abstract] [Full Text]
Petraitis, V., Petraitiene, R., Lin, P., Calis, K., Kelaher, A. M., Muray, H. A., Mya-San, C., Mickiene, D., Bacher, J., Walsh, T. J. (2005). Efficacy and Safety of Generic Amphotericin B in Experimental Pulmonary Aspergillosis. Antimicrob. Agents Chemother. 49: 1642-1645 [Abstract] [Full Text]
Ghannoum, M. A., Chaturvedi, V., Espinel-Ingroff, A., Pfaller, M. A., Rinaldi, M. G., Lee-Yang, W., Warnock, D. W. (2004). Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes. J. Clin. Microbiol. 42: 2977-2979 [Abstract] [Full Text]
Kiso, T., Fujita, K.-I., Ping, X., Tanaka, T., Taniguchi, M. (2004). Screening for Microtubule-Disrupting Antifungal Agents by Using a Mitotic-Arrest Mutant of Aspergillus nidulans and Novel Action of Phenylalanine Derivatives Accompanying Tubulin Loss. Antimicrob. Agents Chemother. 48: 1739-1748 [Abstract] [Full Text]
Petraitiene, R., Petraitis, V., Lyman, C. A., Groll, A. H., Mickiene, D., Peter, J., Bacher, J., Roussillon, K., Hemmings, M., Armstrong, D., Avila, N. A., Walsh, T. J. (2004). Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits. Antimicrob. Agents Chemother. 48: 1188-1196 [Abstract] [Full Text]
Kuzucu, C., Rapino, B., McDermott, L., Hadley, S. (2004). Comparison of the Semisolid Agar Antifungal Susceptibility Test with the NCCLS M38-P Broth Microdilution Test for Screening of Filamentous Fungi. J. Clin. Microbiol. 42: 1224-1227 [Abstract] [Full Text]
Dannaoui, E., Meletiadis, J., Tortorano, A.-M., Symoens, F., Nolard, N., Viviani, M.-A., Piens, M.-A., Lebeau, B., Verweij, P. E., Grillot, R. (2004). Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients. J Med Microbiol 53: 129-134 [Abstract] [Full Text]
Gil-Lamaignere, C., Roilides, E., Lyman, C. A., Simitsopoulou, M., Stergiopoulou, T., Maloukou, A., Walsh, T. J. (2003). Human Phagocytic Cell Responses to Scedosporium apiospermum (Pseudallescheria boydii): Variable Susceptibility to Oxidative Injury. Infect. Immun. 71: 6472-6478 [Abstract] [Full Text]
Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., Territo, M. C. (2003). Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial. ANN INTERN MED 138: 705-713 [Abstract] [Full Text]
Pfaller, J. B., Messer, S. A., Hollis, R. J., Diekema, D. J., Pfaller, M. A. (2003). In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICs. J. Clin. Microbiol. 41: 1126-1129 [Abstract] [Full Text]
Davis, S. R., Perrie, R., Apitz-Castro, R. (2003). The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum). J Antimicrob Chemother 51: 593-597 [Abstract] [Full Text]
Espinel-Ingroff, A. (2003). Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991). J. Clin. Microbiol. 41: 403-409 [Abstract] [Full Text]
Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]
Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A., Rinaldi, M. G. (2002). Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative Study. J. Clin. Microbiol. 40: 3776-3781 [Abstract] [Full Text]
Espinel-Ingroff, A., Fothergill, A., Peter, J., Rinaldi, M. G., Walsh, T. J. (2002). Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study. J. Clin. Microbiol. 40: 3204-3208 [Abstract] [Full Text]
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Verweij, P. E. (2002). Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus Species. J. Clin. Microbiol. 40: 2876-2885 [Abstract] [Full Text]
Rath, P.-M., Freise, J. M., Ansorg, R. (2002). Susceptibility testing of Aspergillus spp. by means of an automated blood culture system. J Antimicrob Chemother 50: 115-117 [Abstract] [Full Text]
Pujol, I., Capilla, J., Fernandez-Torres, B., Ortoneda, M., Guarro, J. (2002). Use of the Sensititre Colorimetric Microdilution Panel for Antifungal Susceptibility Testing of Dermatophytes. J. Clin. Microbiol. 40: 2618-2621 [Abstract] [Full Text]
Verweij, P. E., Te Dorsthorst, D. T. A., Rijs, A. J. M. M., De Vries-Hospers, H. G., Meis, J. F. G. M. (2002). Nationwide Survey of In Vitro Activities of Itraconazole and Voriconazole against Clinical Aspergillus fumigatus Isolates Cultured between 1945 and 1998. J. Clin. Microbiol. 40: 2648-2650 [Abstract] [Full Text]
Espinel-Ingroff, A., Rezusta, A. (2002). E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. J. Clin. Microbiol. 40: 2101-2107 [Abstract] [Full Text]
Hayashi, S., Naitoh, K., Matsubara, S., Nakahara, Y., Nagasawa, Z., Tanabe, I., Kusaba, K., Tadano, J., Nishimura, K., Sigler, L. (2002). Pulmonary Colonization by Chrysosporium zonatum Associated with Allergic Inflammation in an Immunocompetent Subject. J. Clin. Microbiol. 40: 1113-1115 [Abstract] [Full Text]
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., Schuster, M., Reboli, A., Wingard, J., Arndt, C., Reinhardt, J., Hadley, S., Finberg, R., Laverdiere, M., Perfect, J., Garber, G., Fioritoni, G., Anaissie, E., Lee, J., the National Institute of Allergy and Infectious D, (2002). Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever. NEJM 346: 225-234 [Abstract] [Full Text]
Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Schaufele, R. L., Francesconi, A., Bacher, J., Avila, N. A., Walsh, T. J. (2002). Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia. Antimicrob. Agents Chemother. 46: 12-23 [Abstract] [Full Text]
Woyke, T., Pettit, G. R., Winkelmann, G., Pettit, R. K. (2001). In Vitro Activities and Postantifungal Effects of the Potent Dolastatin 10 Derivative Auristatin PHE. Antimicrob. Agents Chemother. 45: 3580-3584 [Abstract] [Full Text]
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Donnelly, P. J., Verweij, P. E., EUROFUNG Network, (2001). Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antifungal Susceptibility Testing of Aspergillus Species. J. Clin. Microbiol. 39: 4256-4263 [Abstract] [Full Text]
Barchiesi, F., Arzeni, D., Camiletti, V., Simonetti, O., Cellini, A., Offidani, A. M., Scalise, G. (2001). In Vitro Activity of Posaconazole against Clinical Isolates of Dermatophytes. J. Clin. Microbiol. 39: 4208-4209 [Abstract] [Full Text]
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]
Groll, A. H., Mickiene, D., Petraitiene, R., Petraitis, V., Lyman, C. A., Bacher, J. S., Piscitelli, S. C., Walsh, T. J. (2001). Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling. Antimicrob. Agents Chemother. 45: 2845-2855 [Abstract] [Full Text]
Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J. (2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother. 45: 1828-1835 [Abstract] [Full Text]
Mosquera, J., Warn, P. A., Morrissey, J., Moore, C. B., Gil-Lamaignere, C., Denning, D. W. (2001). Susceptibility Testing of Aspergillus flavus: Inoculum Dependence with Itraconazole and Lack of Correlation between Susceptibility to Amphotericin B In Vitro and Outcome In Vivo. Antimicrob. Agents Chemother. 45: 1456-1462 [Abstract] [Full Text]
Petrikkou, E., Rodríguez-Tudela, J. L., Cuenca-Estrella, M., Gómez, A., Molleja, A., Mellado, E. (2001). Inoculum Standardization for Antifungal Susceptibility Testing of Filamentous Fungi Pathogenic for Humans. J. Clin. Microbiol. 39: 1345-1347 [Abstract] [Full Text]
Espinel-Ingroff, A. (2001). Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi. J. Clin. Microbiol. 39: 1360-1367 [Abstract] [Full Text]
Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Piscitelli, S., Candelario, M., Field-Ridley, A., Avila, N., Bacher, J., Walsh, T. J. (2001). Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia. Antimicrob. Agents Chemother. 45: 857-869 [Abstract] [Full Text]
Dannaoui, E., Borel, E., Monier, M.-F., Piens, M.-A., Picot, S., Persat, F. (2001). Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 47: 333-340 [Abstract] [Full Text]
Espinel-Ingroff, A. (2001). In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi. J. Clin. Microbiol. 39: 954-958 [Abstract] [Full Text]
Espinel-Ingroff, A. (2001). Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B, Itraconazole, Posaconazole, Ravuconazole, and Voriconazole. Antimicrob. Agents Chemother. 45: 605-607 [Abstract] [Full Text]
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E. (2001). Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media. J. Clin. Microbiol. 39: 478-484 [Abstract] [Full Text]
Korzets, A., Weinberger, M., Chagnac, A., Goldschmied-Reouven, A., Rinaldi, M. G., Sutton, D. A. (2001). Peritonitis Due to Thermoascus taitungiacus (Anamorph Paecilomyces taitungiacus). J. Clin. Microbiol. 39: 720-724 [Abstract] [Full Text]
Pfaller, M. A., Messer, S. A., Mills, K., Bolmström, A. (2000). In Vitro Susceptibility Testing of Filamentous Fungi: Comparison of Etest and Reference Microdilution Methods for Determining Itraconazole MICs. J. Clin. Microbiol. 38: 3359-3361 [Abstract] [Full Text]
Manavathu, E. K., Cutright, J. L., Loebenberg, D., Chandrasekar, P. H. (2000). A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). J Antimicrob Chemother 46: 229-234 [Abstract] [Full Text]
Arthington-Skaggs, B. A., Warnock, D. W., Morrison, C. J. (2000). Quantitation of Candida albicans Ergosterol Content Improves the Correlation between In Vitro Antifungal Susceptibility Test Results and In Vivo Outcome after Fluconazole Treatment in a Murine Model of Invasive Candidiasis. Antimicrob. Agents Chemother. 44: 2081-2085 [Abstract] [Full Text]
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Donnelly, J. P., Verweij, P. E. (2000). Comparison of NCCLS and 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method. J. Clin. Microbiol. 38: 2949-2954 [Abstract] [Full Text]
DANNAOUI, E., BOREL, E., PERSAT, F., PIENS, M.A., PICOT, S. (2000). Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol 49: 601-606 [Abstract] [Full Text]
Li, R.-K., Ciblak, M. A., Nordoff, N., Pasarell, L., Warnock, D. W., McGinnis, M. R. (2000). In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob. Agents Chemother. 44: 1734-1736 [Abstract] [Full Text]
Llop, C., Pujol, I., Aguilar, C., Sala, J., Riba, D., Guarro, J. (2000). Comparison of Three Methods of Determining MICs for Filamentous Fungi Using Different End Point Criteria and Incubation Periods. Antimicrob. Agents Chemother. 44: 239-242 [Abstract] [Full Text]
Okeke, C. N., Tsuboi, R., Kawai, M., Ogawa, H. (2000). Fluorometric Assessment of In Vitro Antidermatophytic Activities of Antimycotics Based on Their Keratin-Penetrating Power. J. Clin. Microbiol. 38: 489-491 [Abstract] [Full Text]
Provine, H., Hadley, S. (2000). Preliminary Evaluation of a Semisolid Agar Antifungal Susceptibility Test for Yeasts and Molds. J. Clin. Microbiol. 38: 537-541 [Abstract] [Full Text]
Johnson, E. M., Oakley, K. L., Radford, S. A., Moore, C. B., Warn, P., Warnock, D. W., Denning, D. W. (2000). Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 45: 85-93 [Abstract] [Full Text]
Manavathu, E. K., Dimmock, J. R., Vashishtha, S. C., Chandrasekar, P. H. (1999). Proton-Pumping-ATPase-Targeted Antifungal Activity of a Novel Conjugated Styryl Ketone. Antimicrob. Agents Chemother. 43: 2950-2959 [Abstract] [Full Text]
Arikan, S., Lozano-Chiu, M., Paetznick, V., Nangia, S., Rex, J. H. (1999). Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and Fusarium Species. J. Clin. Microbiol. 37: 3946-3951 [Abstract] [Full Text]
Dannaoui, E., Persat, F., Monier, M.-F., Borel, E., Piens, M.-A., Picot, S. (1999). In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole. J Antimicrob Chemother 44: 553-555 [Abstract] [Full Text]
Arthington-Skaggs, B. A., Jradi, H., Desai, T., Morrison, C. J. (1999). Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans. J. Clin. Microbiol. 37: 3332-3337 [Abstract] [Full Text]
Ovechkina, Y. Y., Pettit, R. K., Cichacz, Z. A., Pettit, G. R., Oakley, B. R. (1999). Unusual Antimicrotubule Activity of the Antifungal Agent Spongistatin 1. Antimicrob. Agents Chemother. 43: 1993-1999 [Abstract] [Full Text]
Johnson, E. M., Szekely, A., Warnock, D. W. (1999). In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens. Antimicrob. Agents Chemother. 43: 1260-1263 [Abstract] [Full Text]
Szekely, A., Johnson, E. M., Warnock, D. W. (1999). Comparison of E-Test and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Molds. J. Clin. Microbiol. 37: 1480-1483 [Abstract] [Full Text]
Latge, J.-P. (1999). Aspergillus fumigatus and Aspergillosis. Clin. Microbiol. Rev. 12: 310-350 [Abstract] [Full Text]
Manavathu, E. K., Cutright, J., Chandrasekar, P. H. (1999). Comparative Study of Susceptibilities of Germinated and Ungerminated Conidia of Aspergillus fumigatus to Various Antifungal Agents. J. Clin. Microbiol. 37: 858-861 [Abstract] [Full Text]
Roilides, E., Sigler, L., Bibashi, E., Katsifa, H., Flaris, N., Panteliadis, C. (1999). Disseminated Infection Due to Chrysosporium zonatum in a Patient with Chronic Granulomatous Disease and Review of Non-Aspergillus Fungal Infections in Patients with This Disease. J. Clin. Microbiol. 37: 18-25 [Abstract] [Full Text]
Herreros, E., Martinez, C. M., Almela, M. J., Marriott, M. S., De Las Heras, F. G., Gargallo-Viola, D. (1998). Sordarins: In Vitro Activities of New Antifungal Derivatives against Pathogenic Yeasts, Pneumocystis carinii, and Filamentous Fungi. Antimicrob. Agents Chemother. 42: 2863-2869 [Abstract] [Full Text]
Petraitis, V., Petraitiene, R., Groll, A. H., Bell, A., Callender, D. P., Sein, T., Schaufele, R. L., McMillian, C. L., Bacher, J., Walsh, T. J. (1998). Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits. Antimicrob. Agents Chemother. 42: 2898-2905 [Abstract] [Full Text]
Pettit, R. K., Pettit, G. R., Hazen, K. C. (1998). Specific Activities of Dolastatin 10�and Peptide Derivatives against Cryptococcus neoformans. Antimicrob. Agents Chemother. 42: 2961-2965 [Abstract] [Full Text]
Espinel-Ingroff, A. (1998). Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts. J. Clin. Microbiol. 36: 2950-2956 [Abstract] [Full Text]
Girmenia, C., Luzi, G., Monaco, M., Martino, P. (1998). Use of Voriconazole in Treatment of Scedosporium apiospermum Infection: Case Report. J. Clin. Microbiol. 36: 1436-1438 [Abstract] [Full Text]
Chapman, S. W., Rogers, P. D., Rinaldi, M. G., Sullivan, D. C. (1998). Susceptibilities of Clinical and Laboratory Isolates of Blastomyces dermatitidis to Ketoconazole, Itraconazole, and Fluconazole. Antimicrob. Agents Chemother. 42: 978-980 [Abstract] [Full Text]
Clancy, C. J., Yu, Y. C., Lewin, A., Nguyen, M. H. (1998). Inhibition of RNA Synthesis as a Therapeutic Strategy against Aspergillus and Fusarium: Demonstration of In Vitro Synergy between Rifabutin and Amphotericin B. Antimicrob. Agents Chemother. 42: 509-513 [Abstract] [Full Text]
Odds, F. C., Van Gerven, F., Espinel-Ingroff, A., Bartlett, M. S., Ghannoum, M. A., Lancaster, M. V., Pfaller, M. A., Rex, J. H., Rinaldi, M. G., Walsh, T. J. (1998). Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models. Antimicrob. Agents Chemother. 42: 282-288 [Abstract] [Full Text]
Espinel-Ingroff, A (1998). In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens [In Process Citation]. J. Clin. Microbiol. 36: 198-202 [Abstract] [Full Text]

Antimicrob. Agents Chemother.	Clin. Microbiol. Rev.

Clin. Vaccine Immunol.	ALL ASM JOURNALS